$MRAI

Calabrese Jennifer Rosario sold (to issuer) 50,000 shares of MRAI

Calabrese Jennifer Rosario sold (to issuer) 50,000 shares of Marpai, Inc. (MRAI) on 2025-12-08 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Calabrese Jennifer Rosario
Published Jun 2, 2026, 8:58 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jun 2, 2026, 9:06 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$MRAI
Neutral
medium confidence
Mentioned
$MRAI
Relevance
3/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$MRAINeutralLow
01

Why it matters

This disclosure updates insider ownership records but does not provide new fundamentals (no earnings, guidance, deal, or regulatory action).

02

Market read

Traders may note incremental insider selling, but the lack of disclosed price/value and the 10b5-1 structure make it low-signal for near-term trading decisions.

03

What to watch

The transaction price/value is not disclosed, and the sale date (2025-12-08) predates the filing, reducing immediacy and interpretability.

Relevance 3/10Novelty 2/10Timing: SEC Form 4 filed today (2026-06-02) disclosing a 2025-12-08 sale

Background

The article is an SEC EDGAR Form 4 insider transaction: director Calabrese sold 50,000 shares to the issuer on 2025-12-08 under a pre-arranged 10b5-1 plan; the filing was made 2026-06-02.

Company-level read

Ticker impact

$MRAINeutralMedium confidence
Context

Marpai director Calabrese sold 50,000 shares to the issuer under a pre-arranged 10b5-1 plan, disclosed via SEC Form 4.

Expected impact

Low likelihood of a sustained price move from this single Form 4; any reaction is likely limited and short-lived.

Evidence & confidence

The filing is an ownership-change disclosure with no disclosed transaction price/value and no accompanying company-specific operational or financial news.

Market effects

Minimal—this is company-specific insider transaction disclosure, not a sector/regulatory development.

None indicated.

None indicated.

Counterpoint

Because the sale is to the issuer under a 10b5-1 plan, it may reflect routine liquidity/plan mechanics rather than negative views on the stock.

Key entities

  • Marpai, Inc.

    Subject of the Form 4 insider transaction; director sold shares to the issuer under a 10b5-1 plan.

  • Jennifer Rosario Calabrese

    Director who sold 50,000 shares to the issuer; holdings after transaction: 225,000 shares.

Related articles

$MRAIMedAI 8/10

Marpai Announces $12 Million Private Placement led by Mitchell Companies

Marpai, Inc. (OTCQX: MRAI) said it completed securities purchase agreements for a $12 million private placement of newly designated convertible preferred stock led by Mitchell Companies. The deal sold 12,100 shares at $1,000 each with a $1.00 initial conversion price. Preferred holders receive an 8% dividend in common shares and convert on a liquidity event or qualified public offering.